LivaNova PLC - Ordinary Shares (LIVN): Price and Financial Metrics
GET POWR RATINGS... FREE!
LIVN POWR Grades
- LIVN scores best on the Growth dimension, with a Growth rank ahead of 94.48% of US stocks.
- LIVN's strongest trending metric is Stability; it's been moving up over the last 31 weeks.
- LIVN ranks lowest in Momentum; there it ranks in the 15th percentile.
LIVN Stock Summary
- LIVN's went public 5.78 years ago, making it older than merely 19.63% of listed US stocks we're tracking.
- Price to trailing twelve month operating cash flow for LIVN is currently 91.06, higher than 95.34% of US stocks with positive operating cash flow.
- In terms of twelve month growth in earnings before interest and taxes, LivaNova PLC is reporting a growth rate of 105.3%; that's higher than 84.25% of US stocks.
- If you're looking for stocks that are quantitatively similar to LivaNova PLC, a group of peers worth examining would be EVH, HP, DZSI, SANW, and MYGN.
- Visit LIVN's SEC page to see the company's official filings. To visit the company's web site, go to www.livanova.com.
LIVN Valuation Summary
- In comparison to the median Healthcare stock, LIVN's price/earnings ratio is 128.82% lower, now standing at -9.8.
- Over the past 70 months, LIVN's price/earnings ratio has gone down 82.8.
- Over the past 70 months, LIVN's price/earnings ratio has gone down 82.8.
Below are key valuation metrics over time for LIVN.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| LIVN | 2020-05-20 | 2.4 | 1.8 | -24.7 | -19.6 |
| LIVN | 2020-02-26 | 2.8 | 2.0 | -13.6 | -11.0 |
| LIVN | 2019-02-27 | 4.9 | 2.5 | -48.9 | -109.7 |
| LIVN | 2019-02-12 | 5.1 | 2.6 | -50.6 | -113.5 |
| LIVN | 2018-05-18 | 4.2 | 2.2 | -175.9 | 127.8 |
| LIVN | 2015-11-11 | 4.4 | 40606.6 | 66.0 | 48.9 |
LIVN Price Target
For more insight on analysts targets of LIVN, see our LIVN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $95.17 | Average Broker Recommendation | 1.5 (Moderate Buy) |
LIVN Stock Price Chart Interactive Chart >
LIVN Price/Volume Stats
| Current price | $86.07 | 52-week high | $90.25 |
| Prev. close | $83.49 | 52-week low | $41.07 |
| Day low | $85.00 | Volume | 2,156,600 |
| Day high | $88.41 | Avg. volume | 405,711 |
| 50-day MA | $82.56 | Dividend yield | N/A |
| 200-day MA | $72.28 | Market Cap | 4.22B |
LivaNova PLC - Ordinary Shares (LIVN) Company Bio
LivaNova PLC. offers cardiac surgery, cardiac rhythm management, and neuromodulation related products worldwide. The company was founded in 1987 and is based in London, England.
LIVN Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $86.07 | $0.18 | -100% |
We started the process of determining a valid price forecast for LivaNova PLC with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that LivaNova PLC ranked in the 0th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of LivaNova PLC, consider:
- The compound growth rate in the free cash flow of LivaNova PLC over the past 4.16 years is -0.31%; that's better than only 5.86% of cash flow producing equities in the Healthcare sector, where it is classified.
- LivaNova PLC's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -6.04. This coverage rate is greater than that of only 9.87% of stocks we're observing for the purpose of forecasting via discounted cash flows.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -100% |
| 1% | -100% |
| 2% | -100% |
| 3% | -100% |
| 4% | -100% |
| 5% | -100% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as LIVN, try AGHC, AMYT, CRY, CSTL, and EDAP.
Latest LIVN News From Around the Web
Below are the latest news stories about LivaNova PLC that investors may wish to consider to help them evaluate LIVN as an investment opportunity.
LivaNova prices 3.6M-share offering at $82.50LivaNova (NASDAQ:LIVN) has priced its public offering of 3,636,364 ordinary shares at $82.50/share. Underwriters' over-allotment is an additional 545,454 shares. Expected net proceeds of ~$280.1M will be used to partially fund the repayment of its existing $450M five-year senior secured term loan. Closing date is August 6. Goldman Sachs, Barclays... |
Global Surgical Robots for the Spines Market 2021 Top Growing Companies Analysis and Segmentation Outlook till 2028- Medtronic, Boston Scientific, LivaNova, Nevro, NeuroPaceA recently updated report based namely Global Surgical Robots for the Spine Market Research Report 2021-2028 mainly elaborates the definition, types, applications, and major players of the market in detail. The report contains an overview of the market with a |
Global Implantable Neurostimulation Devicess Market 2021 Top Growing Companies Analysis and Segmentation Outlook till 2028- Medtronic, Boston Scientific, LivaNova, Nevro, NeuroPaceA recently updated report based namely Global Implantable Neurostimulation Devices Market Research Report 2021-2028 mainly elaborates the definition, types, applications, and major players of the market in detail. The report contains an overview of the market with a prime focus |
Want To Know the Future of Global Extracorporeal Membrane Oxygenation (ECMO) Devices Market Report 2021-2030 | EUROSETS, LivaNova PLC, ALung TechnologiesThe need for respiratory care has grown in recent times owing to various contributing factors for lung disorders. Along with traditional disorders, cases related to newer disorders have observed to grow over the years. The severity of these disorders on |
Significant Growth in Self-Charging Pacemakers Market by 2021-2028 with Profiling Key Players | Medtronic, Abbott, Boston Scientific, Biotronik, LivaNova, PacetronixThis Self-Charging Pacemakers Market report gives exhaustive bits of knowledge into the different industry characteristics like approaches, patterns and key players working in various districts. In arrange to supply exact and critical information related to showcase situation and development, examiners |
LIVN Price Returns
| 1-mo | 5.87% |
| 3-mo | 3.71% |
| 6-mo | 27.27% |
| 1-year | 81.66% |
| 3-year | -29.14% |
| 5-year | 41.10% |
| YTD | 30.00% |
| 2020 | -12.22% |
| 2019 | -17.54% |
| 2018 | 14.45% |
| 2017 | 77.72% |
| 2016 | -24.25% |
Continue Researching LIVN
Want to do more research on LivaNova PLC's stock and its price? Try the links below:LivaNova PLC (LIVN) Stock Price | Nasdaq
LivaNova PLC (LIVN) Stock Quote, History and News - Yahoo Finance
LivaNova PLC (LIVN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...